Patent directory · USPTO A61K / A61P
Patents matching “inhibitors”
2,466 pharma patents match "inhibitors" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,466 pharmaceutical patents matching "inhibitors" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12269805
Inhibitors of platelet function and methods for use of the same
granted -
US 12268694
Combination pharmaceutical agents as RSV inhibitors
granted -
US 12268673
Anhydrous compositions of mTOR inhibitors and methods of use
granted -
US 12263156
Use of small molecule inhibitors of the BfrB:Bfd interaction in biofilms
granted -
TW 202513047
KAT6 inhibitors
granted -
US 12264149
Indazole compounds as kinase inhibitors
granted -
US 12264167
Fused tricyclic ring derivatives as SRC homology-2 phosphate inhibitors
granted -
US 12264169
Heteroaryl inhibitors of PDE4
granted -
US 12263165
Small molecule inhibitors of cancer stem cells and mesenchymal cancer types
granted -
US 12264158
Protein kinase MKK4 inhibitors for promoting liver regeneration or reducing or preventing hepatocyte death
granted -
US 12252493
Imidazo[1,2-c]pyrimidine derivatives as PRC2 inhibitors for treating cancer
granted -
US 12251387
Substituted quinoxalines and benzo[c][1,2,5]oxadiazoles as DNA-PK inhibitors
granted -
US 12251370
Small molecule inhibitors of the BfrB:Bfd interaction
granted -
US 12252497
Ras inhibitors
granted -
US 12233051
Treating primary or idiopathic hyperoxaluria with small molecule inhibitors of lactate dehydrogenase
granted -
US 12234460
Methods of treating decreased bone mineral density with cluster of differentiation 109 (CD109) inhibitors
granted -
US 12226425
Inhibitors of ARG1 and/or ARG2
granted -
US 12227508
TGF-β inhibitors
granted -
US 12220421
Inhibitors of C. difficile spore germination
granted -
US 12220415
WEE1 kinase inhibitors and methods of treating cancer using the same
granted -
US 12221491
PSMD9 inhibitors for the treatment of hepatic lipid dysregulation
granted -
US 12221441
Plasma kallikrein inhibitors and uses thereof
granted -
US 12213973
Bacterial nitric oxide synthase inhibitors
granted -
US 12219327
Substituted isoindolines as PI3K-alpha inhibitors
granted